COVID-19s silver lining accelerated vaccine development
COVID-19s silver lining accelerated vaccine development
Vaccine development is a lengthy process—it is expensive, attrition is high, and to get a licensed vaccine to everyone, it takes multiple candidate iterations. Vaccine development for pandemics and epidemics is risky, and due to the novel nature of viruses, certain unknown factors can derail a vaccine program.

Added Date:

2021-03-18

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • March
Capability
  • Steriles
Year
  • 2021
Asset Type
  • Blog
Expert
  • Vincenza Pironti
Region
  • Global
Market Category
  • Large molecule

Country Availability:


()

Gated Form:

None Set